Madison K. Royse

Jul 18, 2024 | pubs.rsc.org | Madison K. Royse |Martha Fowler |Yufang He |A. Kristen Mai

Development of a 3D printed perfusable in vitro blood–brain barrier model for use as a scalable screening tool† Despite recent technological advances in drug discovery, the success rate for neurotherapeutics remains alarmingly low compared to treatments for other areas of the body. One of the biggest challenges for delivering therapeutics to the central nervous system (CNS) is the presence of the blood–brain barrier (BBB).